| Autor: |
Fan J; Department of Internal Medicine, Baylor Scott and White HealthTempleTexas., Lipatov K; Department of Internal Medicine, Baylor Scott and White HealthTempleTexas., Lane W; Division of Cardiology, Baylor Scott and White HealthTempleTexas., Mixon T; Division of Cardiology, Baylor Scott and White HealthTempleTexas. |
| Jazyk: |
angličtina |
| Zdroj: |
Proceedings (Baylor University. Medical Center) [Proc (Bayl Univ Med Cent)] 2018 Sep 21; Vol. 31 (4), pp. 496-498. Date of Electronic Publication: 2018 Sep 21 (Print Publication: 2018). |
| DOI: |
10.1080/08998280.2018.1494495 |
| Abstrakt: |
Valvular thrombosis is a known complication of bioprosthetic valve replacement that usually occurs within a year of implantation. Four-dimensional computed tomography is quickly becoming the gold standard to directly visualize thrombus. Current guidelines for prophylaxis include aspirin for all bioprosthetic valve replacements, dual antiplatelet therapy for aortic valves, and anticoagulation for mitral valves. However, new trials have suggested single-agent antiplatelet therapy or anticoagulation for treatment of bioprosthetic valve thrombosis. Three cases are presented that illustrate the use of anticoagulants and new techniques for detecting thrombosis on imaging. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
